|
||||||||||||||||||||||
| cDNA第一鏈反轉(zhuǎn)錄試劑盒采用穩(wěn)定高效的反轉(zhuǎn)錄預(yù)混體系5×Golden RT MasterMix進(jìn)行RNA的反轉(zhuǎn)錄反應(yīng),使用時(shí)只需加入模板、引物和RNase Free H2O 即可,大大簡(jiǎn)化了操作過程、提高了效率、減少了操作過程中的人為誤差。MasterMix中添加了HL dsDNase(熱敏雙鏈特異性核酸酶),該雙鏈特異性核酸酶(又名gDNA Remover)可在反轉(zhuǎn)錄的過程中,直接降解去除RNA中殘留的基因組DNA污染(可去除100ng基因組DNA),從而在定量PCR的檢測(cè)中無需考慮基因組污染的干擾,設(shè)計(jì)的定量PCR引物也無需進(jìn)行橫跨外顯子。該試劑盒尤其適用于定量PCR檢測(cè)。 該預(yù)混體系包含點(diǎn)突變致RNase H活性缺失的Golden MLV Reverse Transcriptase反轉(zhuǎn)錄酶、dNTP、反應(yīng)Buffer、gDNA去除試劑和RNase Inhibitor。該試劑盒采用的反轉(zhuǎn)錄酶去除了RNase H活性,從而避免反轉(zhuǎn)錄過程中降解RNA。同時(shí)經(jīng)過突變文庫篩選,使得其熱穩(wěn)定性更強(qiáng),可耐受55℃高溫反應(yīng)。相比于低溫條件下反轉(zhuǎn)錄反應(yīng),采用高溫反轉(zhuǎn)錄可顯著打開RNA二級(jí)結(jié)構(gòu),從而提高復(fù)雜RNA模板的擴(kuò)增性能、提高反轉(zhuǎn)錄cDNA的長(zhǎng)度和產(chǎn)量,從而提高后續(xù)檢測(cè)的靈敏度。合成的第一鏈cDNA可廣泛用于2nd Strand的合成、雜交、PCR擴(kuò)增、Real-Time PCR反應(yīng)等。 |
||||||||||||||||||||||
組分 |
||||||||||||||||||||||
|
||||||||||||||||||||||
| 注:1.該制品可有效反轉(zhuǎn)錄mRNA、tRNA、LncRNA、ncRNA。 ??2. 該制品不可反轉(zhuǎn)錄microRNA、病毒DNA/RNA樣品。 |
||||||||||||||||||||||
主要特征 |
||||||||||||||||||||||
|
||||||||||||||||||||||
![]() |
||||||||||||||||||||||
儲(chǔ)存 |
||||||||||||||||||||||
| 請(qǐng)置于-20°C,可保存2年;避免反復(fù)凍融。注:如5×Golden RT MasterMix(with dsDNase)出現(xiàn)沉淀屬正常現(xiàn)象,可用手捂化,混合均勻后使用不影響實(shí)驗(yàn)結(jié)果。 | ||||||||||||||||||||||
應(yīng)用本產(chǎn)品文獻(xiàn) |
||||||||||||||||||||||
| 1.Therapeutic effects of hepatocyte growth factor-overexpressing dental pulp stem cells on liver cirrhosis in a rat model. 2.Nrf2 mediates the protective effects of homocysteine by increasing the levels of GSH content in HepG2 cells. 3.Overexpression of phosphoprotein enriched in astrocytes 15 reverses the damage induced by propofol in hippocampal neurons. 4.Nuclear factor erythroid 2-related factor 2 activation mediates hyperhomocysteinemia-associated lipolysis suppression in adipocytes. 5.Apoptin‐derived peptide reverses cisplatin resistance in gastric cancer through the PI3K–AKT signaling pathway. 6.A peptide derived from apoptin inhibits glioma growth. 7.Combined treatment with simvastatin and rapamycin attenuates cardiac allograft rejection through the regulation of T helper 17 and regulatory T cells. 8.MicroRNA‐365 modulates astrocyte conversion into neuron in adult rat brain after stroke by targeting Pax6. 9.Inhibitory effect of HuR gene small interfering RNA segment on laryngeal carcinoma Hep-2 cell growth. 10.Development of reverse transcription loop-mediated isothermal amplification for rapid detection of porcine epidemic diarrhea virus. 11.Local Expression of Insulin-Like Growth Factor-I,Insulin-Like Growth Factor-I Receptor, and Estrogen Receptor Alpha in Ovarian Cancer. 12.Inhibitory Effect of Small Interfering RNA Targeting Insulin-Like Growth Factor-I Receptor in Ovarian Cancer OVCAR3 Cells. |
||||||||||||||||||||||
Golden 1st cDNA Synthesis Kit說明書
作者:上海信裕生物科技有限公司 2021-05-18T00:00 (訪問量:2114)
上海信裕生物科技有限公司 商家主頁
地 址: 上海市閔行莘莊工業(yè)區(qū)春東路508號(hào)A1-2F
聯(lián)系人: 徐經(jīng)理
電 話: 021-60526354
傳 真: 021-37680378
Email:shxysw02@163.com
相關(guān)咨詢
2018年春節(jié)放假通知 (2018-02-06T17:43 瀏覽數(shù):30166)
新技術(shù)可更準(zhǔn)確預(yù)測(cè)中風(fēng)風(fēng)險(xiǎn) (2017-09-13T12:02 瀏覽數(shù):28286)
Cell:科學(xué)家成功利用在體電場(chǎng)刺激引導(dǎo)神經(jīng)干細(xì)胞定向運(yùn)動(dòng) (2017-07-21T11:06 瀏覽數(shù):30094)
系統(tǒng)性異質(zhì)性:一種理解腫瘤異質(zhì)性的綜合性方法 (2017-07-17T15:34 瀏覽數(shù):27461)
輝瑞靶向抗癌藥Mylotarg獲美國(guó)FDA專家委員會(huì)支持治療急性髓性白血病(AML) (2017-07-14T16:24 瀏覽數(shù):27820)
表觀遺傳的腫瘤異質(zhì)性 (2017-07-10T11:19 瀏覽數(shù):26451)
重大發(fā)現(xiàn)!特殊的自然殺傷細(xì)胞亞群或能增加個(gè)體患糖尿病的風(fēng)險(xiǎn) (2017-07-07T11:05 瀏覽數(shù):25712)
臨床試驗(yàn)表明:針灸療法或有望幫助減肥 (2017-07-05T10:44 瀏覽數(shù):29797)
研究揭示瘧原蟲感染小鼠血漿外泌體抑制腫瘤血管生成的分子機(jī)制 (2017-07-03T14:52 瀏覽數(shù):29620)
研究人員成功開發(fā)出益生菌啤酒,讓你舉杯更健康! (2017-06-30T12:33 瀏覽數(shù):30054)

